Status:
COMPLETED
Safety And Efficacy Of Rifabutin In HIV Patients
Lead Sponsor:
Pfizer
Conditions:
Non-tuberculous Mycobacterial Diseases
Tuberculosis
Eligibility:
All Genders
Brief Summary
The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in thi...
Detailed Description
All the patients whom an investigator prescribes the first Mycobutin® should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into t...
Eligibility Criteria
Inclusion
- Patients need to be administered Mycobutin® in order to be enrolled in the surveillance.
Exclusion
- Patients not administered Mycobutin®.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00810446
Start Date
June 1 2009
End Date
March 1 2018
Last Update
August 2 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.